The PsyKey – MycoVita strategic partnership is focused on the research, development, and commercialization of Mycology based formulations, products, and therapeutics. including the research of psilocybin and its benefits as a medicinal therapeutic.
MycoVita, whose name is derived from Latin meaning “mushroom life” is a Biotech company focused on the development of functional foods and products that support optimal health and wellbeing through science backed formulations and research by its world class mycology team.
MycoVita was founded by Dr. Omon Isikhuemhen who is currently a leading mushroom science and fungal biotechnology professor. Dr. Isikhuemhen credentials include a Bachelor of Science with honors, a Masters of Science in Botany, as well as a Ph.D in Microbiology. Dr. Isikhuemhen is a trailblazer in research and development that has resulted in many technological advancements, products, and numerous scientific publications.
Mushrooms and their derived bio-products offer unique benefits for both the body and mind, ranging from immune support, cognition and memory enhancement, to energy and stamina boost. MycoVita is targeting these areas to deliver measurable results for healthy outcomes.